Emergent BioSolutions, Inc. (EBS)
5.17
+0.09
(+1.77%)
USD |
NYSE |
Aug 24, 16:00
5.17
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Total Liabilities (Quarterly) : 775.40M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 775.40M |
| March 31, 2026 | 797.30M |
| December 31, 2025 | 809.40M |
| September 30, 2025 | 878.50M |
| June 30, 2025 | 880.90M |
| March 31, 2025 | 873.40M |
| December 31, 2024 | 914.10M |
| September 30, 2024 | 969.40M |
| June 30, 2024 | 1.127B |
| March 31, 2024 | 1.140B |
| December 31, 2023 | 1.186B |
| September 30, 2023 | 1.196B |
| June 30, 2023 | 1.222B |
| March 31, 2023 | 1.747B |
| December 31, 2022 | 1.779B |
| September 30, 2022 | 1.459B |
| June 30, 2022 | 1.222B |
| March 31, 2022 | 1.205B |
| December 31, 2021 | 1.346B |
| September 30, 2021 | 1.345B |
| June 30, 2021 | 1.372B |
| March 31, 2021 | 1.377B |
| December 31, 2020 | 1.436B |
| September 30, 2020 | 1.365B |
| June 30, 2020 | 1.267B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.204B |
| December 31, 2019 | 1.239B |
| September 30, 2019 | 1.299B |
| June 30, 2019 | 1.332B |
| March 31, 2019 | 1.166B |
| December 31, 2018 | 1.218B |
| September 30, 2018 | 206.97M |
| June 30, 2018 | 200.54M |
| March 31, 2018 | 187.19M |
| December 31, 2017 | 157.86M |
| September 30, 2017 | 360.49M |
| June 30, 2017 | 349.88M |
| March 31, 2017 | 341.22M |
| December 31, 2016 | 373.91M |
| September 30, 2016 | 384.40M |
| June 30, 2016 | 383.79M |
| March 31, 2016 | 368.92M |
| December 31, 2015 | 377.47M |
| September 30, 2015 | 371.24M |
| June 30, 2015 | 381.07M |
| March 31, 2015 | 379.97M |
| December 31, 2014 | 392.06M |
| September 30, 2014 | 356.15M |
| June 30, 2014 | 349.48M |
| March 31, 2014 | 345.76M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Exelixis, Inc. | 650.47M |
| Capricor Therapeutics, Inc. | 122.52M |
| ADMA Biologics, Inc. | 276.00M |
| Akebia Therapeutics, Inc. | 324.64M |
| Arcutis Biotherapeutics, Inc. | 267.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.117B |
| Shareholders Equity (Quarterly) | 341.40M |
| Debt to Equity Ratio | 1.723 |
| Current Ratio | 5.424 |
| Net Debt Paydown Yield | 3.93% |